These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1328903)

  • 1. [Guillain-Barré disease: a current treatment method using immunoglobulins].
    Kleyweg RP; van der Meché FG
    Ned Tijdschr Geneeskd; 1992 Oct; 136(40):1956-60. PubMed ID: 1328903
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe Guillain-Barré syndrome associated with Campylobacter jejuni infection with failure to respond to plasmapheresis and immunoglobulin.
    Allen A; Antony SJ
    J Am Board Fam Pract; 1999; 12(3):249-52. PubMed ID: 10395423
    [No Abstract]   [Full Text] [Related]  

  • 3. Campylobacter jejuni infection and Guillain-Barre syndrome.
    Aguago JM; Ramos JT; Lumbreras C
    N Engl J Med; 1996 Mar; 334(12):802. PubMed ID: 8592566
    [No Abstract]   [Full Text] [Related]  

  • 4. [Campylobacter jejuni and cytomegalovirus (CMV) infections in patients with the Guillain-Barre syndrome].
    Orlikowski D; Quijano-Roy S; Sivadon-Tardy V; Raphael JC; Gaillard JL
    Arch Pediatr; 2006 Dec; 13(12):1561-5. PubMed ID: 17030119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Campylobacter jejuni bacteremia and Guillain-Barré syndrome in a patient with GVHD after allogeneic BMT.
    Hagensee ME; Benyunes M; Miller JA; Spach DH
    Bone Marrow Transplant; 1994 Mar; 13(3):349-51. PubMed ID: 8199580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?].
    Martínez Yélamos A; Huerta Villanueva M; Olivé Plana M; Montero Homs J; Serra Catafau J; Martínez-Matos JA
    Neurologia; 1998 Apr; 13(4):166-9. PubMed ID: 9608755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
    Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O
    Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously?
    van der Meché FG
    Ann Med Interne (Paris); 1994; 145(5):293-5. PubMed ID: 7985934
    [No Abstract]   [Full Text] [Related]  

  • 9. Guillain-Barré syndrome.
    Pemberton L
    Nurs Times; 1998 Nov 18-24; 94(46):50-3. PubMed ID: 9923382
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome.
    Gürses N; Uysal S; Cetinkaya F; Işlek I; Kalayci AG
    Scand J Infect Dis; 1995; 27(3):241-3. PubMed ID: 8539548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Campylobacter jejuni Infection and treatment for Guillain-Barré Syndrome.
    Jacobs BC; Schmitz PI; van der Meche FG
    N Engl J Med; 1996 Jul; 335(3):208-9. PubMed ID: 8657230
    [No Abstract]   [Full Text] [Related]  

  • 12. The Guillain-Barré syndrome following Campylobacter enteritis with recovery after plasmapheresis.
    Constant OC; Bentley CC; Denman AM; Lehane JR; Larson HE
    J Infect; 1983 Jan; 6(1):89-91. PubMed ID: 6886449
    [No Abstract]   [Full Text] [Related]  

  • 13. Guillain-Barré syndrome after heart transplantation.
    Baldwin RT; Pierce RR; Frazier OH
    J Heart Lung Transplant; 1992; 11(4 Pt 1):817-9. PubMed ID: 1323331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose intravenous immune globulin for treatment of Guillain-Barré syndrome.
    McGhee B; Jarjour IT
    Am J Hosp Pharm; 1994 Jan; 51(1):97-9. PubMed ID: 8135270
    [No Abstract]   [Full Text] [Related]  

  • 15. Guillain-Barré syndrome.
    Winer J
    Br J Hosp Med; 1994 Mar 16-Apr 5; 51(6):313. PubMed ID: 8032572
    [No Abstract]   [Full Text] [Related]  

  • 16. [Guillain-Barré syndrome associated with cytomegalovirus infection after kidney transplantation].
    Lloveras JJ; Larrue V; Delisle MB; Tack I; Icart J; Dupré C; Ton That H; Durand D; Suc JM
    Presse Med; 1994 Jun; 23(21):976-8. PubMed ID: 7937644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts in Guillain-Barré syndrome.
    Franco DA; Bashir RM
    Nebr Med J; 1996 Dec; 81(12):406-11. PubMed ID: 9046790
    [No Abstract]   [Full Text] [Related]  

  • 18. Second response to immunoglobulin in recurrent Guillain-Barré syndrome.
    Nagappan R; Barker J
    N Z Med J; 1998 Nov; 111(1077):433-4. PubMed ID: 9861925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of intravenous immunoglobulins in Guillain-Barré syndrome].
    Ceccarelli M; Assanta N; Chiaravalloti G; Rocopou C; Caiulo VA
    Minerva Pediatr; 1992 May; 44(5):237-40. PubMed ID: 1620076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmapheresis vs intravenous immunoglobulin treatment in childhood Guillain-Barré syndrome.
    Vajsar J; Sloane A; Wood E; Murphy EG
    Arch Pediatr Adolesc Med; 1994 Nov; 148(11):1210-2. PubMed ID: 7921126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.